A carregar...
Publicação
Tissue structure developer: jellyfish-based collagen as an innovative wound healing treatment - business strategy, market analysis & architecture
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 1.93 MB | Adobe PDF |
Autores
Orientador(es)
Resumo(s)
TSD, a novel biotech venture, aims to revolutionise the wound healing market by utilising
jellyfish, a new source of collagen. Its product, the CollaPatchTM, harnesses the benefits of
jellyfish collagen across social, environmental, and ecological dimensions, offering a superior
alternative to bovine- and porcine-based collagen products for wound healing. TSD strives to
capture significant market share in the treatment of both acute and chronic wounds by
presenting a comprehensive business model, covering the diverse user and customer needs,
existing and potential competitors, the optimal path to commercialisation, the required steps in
the development roadmap and valuable funding and exit opportunities.
Descrição
Palavras-chave
Entrepreneurship Intrapreneurship Innovation Venture capital Biotechnology Biomedical innovation Business strategy Intellectual property Pharmaceutical Competitive analysis Funding Ulcers Wound healing